This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now

Dr. Frederic Dargelas, PhD
Senior Director, Head of Business Development and Alliance Management at DelSiTech Ltd.
Presenter

Profile

Dr. Frederic Dargelas is Head of Business Development and Alliance Management of DelSiTech. Dr. Dargelas is a business development and R&D veteran with almost 20 years of experience in the pharma and biotech industry. Previously, he held managing positions at diverse international companies such as GSK, UCB and Orion Pharma. Dr. Dargelas holds a PhD in Physical Chemistry of Polymers and an MBA.

Agenda Sessions

  • Biodegradable Silica Composite Technology Enabling Long-Acting Controlled Release of peptides

    , 2:45pm
    View Session

At this event

Prev
Next
Ratmir Derda, PhD
Founder and CSO, 48 Hour Discovery
University of Alberta

See Frederic at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now